Cargando…
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers
Nolasiban is an orally active oxytocin receptor antagonist being developed to increase the efficiency of assisted reproductive technologies. This study evaluated the pharmacokinetics, pharmacodynamics, and cardiac safety of nolasiban in 45 healthy women of child-bearing age. Nolasiban was administer...
Autores principales: | Täubel, Jörg, Lorch, Ulrike, Spencer, Christopher S., Freier, Anne, Camilleri, Dorothée, Djumanov, Dilshat, Ferber, Georg, Marchand, Line, Gotteland, Jean-Pierre, Pohl, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973531/ https://www.ncbi.nlm.nih.gov/pubmed/33739022 http://dx.doi.org/10.1038/s41598-021-85650-3 |
Ejemplares similares
-
Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study
por: Luo, Huanyuan, et al.
Publicado: (2021) -
Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials
por: Coates, Simon, et al.
Publicado: (2020) -
Confirmation of the Cardiac Safety of PGF(2α) Receptor Antagonist OBE022 in a First‐in‐Human Study in Healthy Subjects, Using Intensive ECG Assessments
por: Täubel, Jörg, et al.
Publicado: (2018) -
Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open‐Label, Randomized Crossover Studies in Healthy Japanese Volunteers
por: Lorch, Ulrike, et al.
Publicado: (2020) -
Concentration‐QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers
por: Täubel, Jӧrg, et al.
Publicado: (2021)